Cinclus Pharma

Cinclus Pharma

Sweden - Stockholm
Pharmaceutical

Focus: GERD Treatment

Cinclus Pharma is a life sciences company focused on GERD Treatment.

Gastroenterology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Linaprazan glurate
Safety Issues
Phase 1
Clinical Trials (1)
NCT05633147Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam
Phase 1
Linaprazan glurate
Pharmacokinetics
Phase 1
Clinical Trials (1)
NCT05469854A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate
Phase 1
Linaprazan glurate
Safety
Phase 1
Clinical Trials (1)
NCT05627518Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation
Phase 1
Single ascending dose of X842
Healthy Volunteers
Phase 1
Clinical Trials (1)
NCT03105375Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Human: A Single/Multiple Ascending Dose Study
Phase 1
Drug Drug Interaction
Drug Interaction
Phase 1
Clinical Trials (1)
NCT07308041A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin
Phase 1
linaprazan glurate 25 mg QD
GERD
Phase 1
Clinical Trials (1)
NCT05742984Investigate Linaprazan Glurate/Linaprazan in Healthy Subjects
Phase 1
Clinical Trials (1)
NCT05055128A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
Phase 2
Linaprazan glurate - High dose
GERD (Gastroesophageal Reflux Disease)
Phase 3
Clinical Trials (1)
NCT07313774A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Maintenance of Healing in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)
Phase 3
Linaprazan glurate 50 mg Twice Daily
GERD (Gastroesophageal Reflux Disease)
Phase 3
Clinical Trials (1)
NCT07037875A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 9 clinical trials